Another Blood Pressure Medication Recalled Over Carcinogen Concerns
EAST WINDSOR, N.J. - Another blood pressure medication has been recalled over concerns it could contain trace amounts of carcinogens. The medication is manufactured by Aurobino Pharma USA, Inc. The recall is voluntary. It affects 80 lots of Amlodipine Valsartan Tablets USP, Valsartan HCTZ Tablets, USP and Valsartan Tablets USP.
Post to Tumblr